Regulation 33 of LODR Act 2015

Revenue Growth 20pctPat Growth 25pctRevenue DeclineResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.3%Reaction day

₹22.70

prior close

₹22.75

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-0.0% vs market

Pharmaceuticals peers, median of 155sector+0.2%+1.0% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.3+1.3-0.0+0.2+1.0

Next day

+1.6+0.3+1.3-0.4+2.0

+1.1-0.5+1.6-1.1+2.2

+1.3+2.1-0.8+0.7+0.7

-0.7+3.1-3.8+1.3-2.0

+2.6+2.6+0.0+1.4+1.2

+2.6+0.6+2.0+0.3+2.3

15d

-3.1-1.4-1.7-2.3-0.8

-11.9-6.9-5.0-5.1-6.8

-10.8-7.7-3.2-7.9-2.9

-5.3+7.0-12.2+0.8-6.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board of Unjha Formulations Ltd, at its meeting on 4 February 2026, approved unaudited financial results for Q3 FY26 and the 9 months ended 31 December 2025. Net sales for the 9-month period stood at Rs 1,386.21 lakhs, up about 20.6% from Rs 1,149.65 lakhs in the same period last year. Profit after tax for 9M jumped to Rs 144.75 lakhs (EPS Rs 3.23) from Rs 81.21 lakhs (EPS Rs 1.81) a year earlier, an increase of around 78% YoY. For the standalone Q3 quarter, net sales fell to Rs 376.24 lakhs from Rs 428.53 lakhs YoY (about a 12% decline), though PAT edged up marginally to Rs 23.97 lakhs from Rs 22.40 lakhs. Statutory auditor Jain & Golechha issued a clean limited review report with no qualifications or emphasis of matter.

Likely market impact

Strong 9M revenue and profit growth, driven by improving margins, is a positive signal for shareholders. However, the Q3 standalone revenue dip may temper near-term sentiment, even as profitability remains broadly stable.